Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

YW2065 is an inhibitor of Wnt/β-catenin signaling and an activator of AMP-activated protein kinase (AMPK).1 It induces degradation of β-catenin and increases the levels of Axin1 and phosphorylated AMPK and acetyl-CoA carboxylase (ACC), which is a downstream substrate of AMPK, in SW620 colorectal cancer cells when used at a concentration of 3 µM. YW2065 inhibits recombinant human Wnt3a-induced reporter activation in HEK293 cells (IC50 = 2.3 nM) and the growth of SW480 colorectal cancer cells (GI50 = 2.4 nM). In vivo, YW2065 (50 mg/kg) decreases tumor volume and weight in an SW620 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Pyrazole-